U.S. Office REITs Stock News

NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Palantir (PLTR) Faces Swiss Legal Loss And French Intelligence Contract Exit

Palantir Technologies (NasdaqGS:PLTR) has reportedly lost a major legal challenge in Switzerland tied to government contracts. Swiss authorities are reassessing or ending Palantir engagements following the ruling, with data sovereignty issues in focus. In parallel, France is replacing Palantir with a domestic provider for sensitive intelligence work. These developments highlight rising European scrutiny of foreign data analytics providers on privacy and national security grounds. Palantir...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx (RARE) Is Up 17.6% After ESOP Share Shelf And Conference Spotlight On Gene Therapies – Has The Bull Case Changed?

In June 2026, Ultragenyx Pharmaceutical Inc. filed a US$81.53 million shelf registration for 3,400,000 common shares linked to an employee stock ownership plan and participated in the Goldman Sachs 47th Annual Global Healthcare Conference, where Founder and CEO Emil D. Kakkis presented the company's rare disease and gene therapy focus. These developments come alongside growing attention on Ultragenyx’s gene therapy pipeline and regulatory tailwinds, which are reshaping how investors assess...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk (NYSE:NVO) Wins UK Approval For Oral Wegovy In Europe First

The UK has approved Novo Nordisk's oral Wegovy pill for chronic weight management. This is the first oral GLP-1 weight-loss therapy cleared in Europe. The decision expands Novo Nordisk's obesity portfolio beyond injectable options. Novo Nordisk (NYSE:NVO) now has the first oral GLP-1 weight-loss treatment approved in Europe, with the UK clearing its oral Wegovy pill for chronic weight management. The decision gives the company a new dosage format alongside its existing injectable obesity...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure (NVCR) Appoints Frank Leonard To Its Board After Shareholder Vote

NovoCure (NasdaqGS:NVCR) has appointed Frank Leonard to its board of directors. The appointment follows shareholder elections held at the company’s recent annual general meeting. This board change introduces a new voice to NovoCure’s governance during an important period for the business. NovoCure enters this board transition with its stock at $17.6 and a mixed recent track record. The share price is up 4.5% over the past week and 34.1% year to date, while the 1 year return is down 1.7% and...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron (MU) Just Raised Its Dividend 30% After Record AI Driven Results

Micron Technology (NasdaqGS:MU) reported record quarterly results, with revenue close to tripling and earnings far ahead of prior expectations. The company issued Q3 guidance that would put a single quarter’s revenue above some previous full-year levels. Micron announced a 30% increase to its dividend alongside results. All of Micron’s 2026 high bandwidth memory supply is now fully contracted under multi-year agreements. Micron Technology stock (NasdaqGS:MU) is coming off an intense run,...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Does Ondas (ONDS) Expanding Defense Backlog Redefine Its Autonomy-First Competitive Positioning?

Recently, Ondas showcased its unified autonomous defense architecture at Eurosatory, introducing systems such as Iron Wave, Dual Shield, MODUS, Scout Cyber-over-RF, Iron Arrow, and LADOS while highlighting its ONBERG European joint venture to support regional manufacturing and deployment. Alongside these technology launches, the company reported very large year-on-year Q1 revenue growth, a substantial US$457 million defense backlog, and deepening AI collaboration with Palantir, underscoring...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Papa John's (PZZA) Stock After Multi‑Year Slide Is The Recent Rebound Enough

If you are wondering whether Papa John's International stock at around US$33 is a bargain or a value trap, the starting point is understanding what the current price actually reflects. The share price is up 4.8% over the last week, yet remains down 4.5% over the last month, 17.7% year to date, and 30.2% over the past year. There have also been longer term declines of 49.8% over three years and 63.3% over five years that may influence how investors see its risk and recovery potential. Recent...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Teradyne (TER) Stock Could Be 15% Overvalued After Its Sharp Run Higher

Teradyne stock: recent performance snapshot Teradyne (TER) has drawn attention after its share price closed at $432.41, with recent returns of 7.2% over the past day, 15.4% over the past week, and around 28% over the past month. See our latest analysis for Teradyne. Beyond the latest daily move, Teradyne stock has shown strong momentum, with a 30 day share price return of 28% and a year to date share price return of 108.3%, alongside a 1 year total shareholder return of very close to 4x. If...
NasdaqGS:PEBO
NasdaqGS:PEBOBanks

Peoples Bancorp (PEBO) Stock After Strong Multi‑Year Gains Are Further Upsides Priced In

If you are wondering whether Peoples Bancorp stock still offers value at around US$35.89, the current pricing sets up an interesting question about what the market is really expecting from the company. Over recent periods, the stock has delivered returns of 1.4% over 7 days, 8.7% over 30 days, 19.0% year to date, 30.4% over 1 year, 50.7% over 3 years, and 53.6% over 5 years. This naturally draws attention to whether the recent share price reflects a fair valuation or not. Recent news...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal (PYPL) Stock Could Be 48.2% Undervalued As New Partnerships Draw Attention

Recent attention on PayPal Holdings (PYPL) has centered on high profile investors publicly flagging the stock as discounted, at the same time that fresh partnerships and leadership changes are reshaping how the payments company talks about its future. See our latest analysis for PayPal Holdings. Despite partnerships like Shopware Payments and Hey Savi’s AI commerce launch putting PayPal Holdings at the center of new payment flows, the recent 1-day and 7-day share price returns of 2.31% and...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

Will Greenskeeper’s Post‑Probe Accumulation of ICON (ICLR) Shares Shift the Company’s Investment Narrative?

In the past quarter, Greenskeeper Asset Management increased its holdings in ICON Public Limited Company after an internal Audit Committee investigation into revenue recognition had weighed on sentiment during a period of geopolitical tension and broader market weakness. Greenskeeper argued that the market reaction to ICON’s accounting review was excessive, using the share price weakness to add to its position based on its assessment of the company’s longer-term potential and...
NYSE:ENS
NYSE:ENSElectrical

The Bull Case For EnerSys (ENS) Could Change Following Pivot To Data Center And Defense Markets

EnerSys recently outlined a refreshed growth roadmap, including the launch of its DataSafe Noir™ lithium-ion system for data centers and a realignment of its lithium cell factory toward aerospace and defense applications, highlighted at its June 11, 2026 Investor Day in New York City. This shift toward higher-value data center and defense markets signals a meaningful reorientation of EnerSys’ portfolio toward sectors where its technology and manufacturing footprint may command stronger...
NasdaqGS:KSPI
NasdaqGS:KSPIConsumer Finance

Kaspi.kz (NasdaqGS:KSPI) Stock Could Be 16% Undervalued After Dividend Affirmation

Kaspi.kz dividend and governance moves come into focus Kaspi.kz (NasdaqGS:KSPI) has drawn fresh attention after affirming a KZT 850 dividend per common share, with payments starting on 11 June 2026, following an extraordinary general meeting. At that meeting, shareholders also approved three members to Kaspi.kz’s Counting commission with an unlimited term of powers. This governance detail sits alongside the dividend decision as investors reassess the stock’s risk and income profile. See our...
NYSE:BE
NYSE:BEElectrical

Bloom Energy Stock And Two Cash Flow Plays Wall Street Underrates

Global markets are wrestling with mixed signals on inflation, growth, and interest rates, which can make it hard to know where to focus. One approach is to look past headlines and concentrate on companies whose cash flows appear solid yet whose share prices sit below an estimate of fair value. That is what the Undervalued Stocks Based On Cash Flows screener targets, using SWS DCF valuation to flag potential mismatches between price and underlying cash generation. In this article, you will see...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Marriott International (MAR) Stock Could Be 27.6% Overvalued After Lefay Deal And 10,000th Opening

Investor focus on Marriott International (MAR) has sharpened after the company announced a joint venture with luxury wellness brand Lefay and celebrated its 10,000th property opening, the JW Marriott Ranthambore Resort & Spa in India. See our latest analysis for Marriott International. Alongside the Lefay joint venture, the Ask Bonvoy AI search launch and Marriott’s 10,000th property milestone have arrived during a period of strong momentum, with a 30 day share price return of 13.44% and a 1...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Should Summit Therapeutics’ Canceled US$500 Million Equity Offering Reshape SMMT Investors’ View on Financing Strategy?

Earlier this month, Summit Therapeutics filed and then withdrew a US$500.00 million follow-on equity offering of 35,435,861 common shares at an indicated US$14.11 price range after announcing positive Phase II/III data for its lead cancer drug ivonescimab in non-small cell lung and metastatic colorectal cancers. The combination of encouraging ivonescimab trial outcomes with a halted equity raise highlights how Summit is balancing funding needs against market conditions as it advances a...
NYSE:WOLF
NYSE:WOLFSemiconductor

Adobe Stock Meets Alphabet And Wolfspeed In This AI Trifecta

Artificial intelligence is cutting across everything from chips and cloud to everyday software, even as central banks weigh inflation, bond markets react to shifting rate expectations, and growth trends look uneven across major economies. That mix of cost pressures, productivity needs, and cautious corporate budgets is pushing many investors to look for AI stocks with clearer links to real products such as semiconductors, large language models, and AI infrastructure. This AI Stocks screener...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

How New Prader‑Willi Phase 2 Setmelanotide Data At Rhythm Pharmaceuticals (RYTM) Has Changed Its Investment Story

Rhythm Pharmaceuticals recently reported preliminary six‑month data from an ongoing Phase 2 trial of setmelanotide in Prader‑Willi syndrome, showing BMI reductions, improved hyperphagia and anxiety scores, and preserved lean mass in 18 patients aged 6–23 years. The data, presented at ENDO 2026, highlight setmelanotide’s potential to address both weight and behavioral aspects of PWS while maintaining lean body composition, an important consideration for future Phase 3 planning. We’ll now...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Cruises (RCL) Stock Could Be 5.6% Overvalued After Travel Sentiment Lift

Royal Caribbean Cruises (RCL) stock moved after renewed optimism around international relations, as a high profile diplomatic agreement lifted sentiment toward global travel, with cruise and airline stocks reacting alongside other beneficiaries of cross border activity. See our latest analysis for Royal Caribbean Cruises. Beyond the latest diplomatic news, Royal Caribbean Cruises has been in the spotlight for operational developments such as the new Seward, Alaska terminal and ongoing...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY) Stock Could Be 6.8% Overvalued After Earnings And New Store Partnerships

Best Buy (BBY) stock has been in focus after earnings highlighted strong cash conversion, alongside fresh store partnerships with Meta and GEEKOM, raising questions about how these moves might shape future cash generation. See our latest analysis for Best Buy. Best Buy’s recent earnings, Meta Lab roll out and new GEEKOM Mini PC partnership come after a sharp 37.54% 30 day share price return. However, the 5 year total shareholder return of an 11.58% decline shows that longer term momentum has...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Nova (NVMI) Is Up 19.2% After Trump Pauses Iran Strikes Easing Geopolitical Tensions - Has The Bull Case Changed?

Earlier this week, President Trump canceled planned military strikes on Iran and signaled possible diplomatic progress, easing immediate geopolitical tensions that had weighed on global markets. The news resonated across semiconductor names such as Nova, highlighting how macro-level political decisions can quickly influence sentiment toward globally exposed chip-equipment suppliers. With geopolitical risk easing for now, we’ll examine how this development fits into Nova’s investment...
NYSE:UBER
NYSE:UBERTransportation

Uber (UBER) Launches New Ad Tools And Extends Brand Reach Beyond Its Apps

Uber Technologies (NYSE:UBER) has announced a major expansion of its advertising business. The company is rolling out new products including trip-based offers and premium ad formats on Uber Eats. Uber is also extending advertisers' reach beyond its own apps to platforms such as Meta and Google Shopping. Uber Technologies has been building beyond its core ride hailing and food delivery services, and this latest move pushes further into advertising. By using trip context and order data to...
NYSE:KGS
NYSE:KGSEnergy Services

Flywire And 2 Other Stocks That May Be Trading Below Their Estimated Value

The United States market has shown a robust performance, climbing 2.2% in the last week and 25% over the past year, with earnings projected to grow by 19% annually in the coming years. In such a thriving environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on undervalued assets.
NasdaqGM:EOLS
NasdaqGM:EOLSPharmaceuticals

Insiders Are Betting Big On These 3 High Growth Stocks

Over the last 7 days, the United States market has risen by 2.2%, and over the past 12 months, it is up by an impressive 25%, with earnings expected to grow by 19% per annum in the coming years. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and future prospects.